chartexchange

TRDA
Entrada Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:54 PM EST
5.04USD+1.613%(+0.08)815,429
After-hoursNov 18, 2026 4:00:30 PM EST
5.03USD-0.198%(-0.01)
Loading…
Loading…
197.12M
Healthcare
Biotechnology
HQ
Boston, MA, USA
Previous Close
$4.96
Beta
1.48
52-Week High
$16.45 2026-05-06
52-Week Low
$4.11 2026-10-14
SMA 50
$5.46
SMA 200
$8.36
Avg. Vol 10D
609,033
Avg. Vol 30D
488,575
Avg. Vol 90D
401,342
Relative Vol
1.67
23.12M
0.7300%
1,031
TRDA Profile

entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.

TRDA Performance
PeriodPriceDateChangeBeta
1W5.172026-11-12-2.61%1.128
1M4.822026-10-19+4.46%1.263
3M7.782026-08-19-35.28%1.421
6M5.652026-05-19-10.88%1.321
1Y8.732025-11-19-42.33%1.477
2Y17.772024-11-19-71.67%—
5Y32.792021-11-19-84.64%1.095
TRDA Stock Summary

Entrada Therapeutics, Inc. Common Stock (NASDAQ:TRDA) stock price today is $5.04, and today's volume is 815,429. TRDA is up 1.512% today. The 30 day average volume is 488,575. TRDA market cap is $197.12M with 39.15M shares outstanding.